Evaluation of Nail Fold Microcirculation in CKD

NCT03682952 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-09-26

No results posted yet for this study

Summary

To evaluation of nailfold microcirculation in patients with chronic renal failure and its intervention therapy

Conditions

  • Chronic Renal Disease

Interventions

DRUG

Alprostadil Injection

Participants are given alprostadil injection 10ug intravenously once a day for 2 weeks.

DRUG

Beraprost sodium tablets

Participants are given alprostadil injection 10ug intravenously once a day for 2 weeks ,then they take beraprost sodium tablets 40ug orally three times perday for 3 months.

Sponsors & Collaborators

  • The Affiliated Hospital of Xuzhou Medical University

    lead OTHER

Principal Investigators

  • Dong Sun, MD · The Affiliated Hospital of Xuzhou Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03682952 on ClinicalTrials.gov